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Versican, an extracellular chondroitin sulfate proteoglycan which binds hyaluronan, has been 
hypothesized to play a role in synovial joint formation in the chick embryo. Several studies have 
shown versican to be involved in mesenchymal aggregation during limb chondrogenesis with 
diminished expression as later stages of limb development occur. Although expression within the 
cartilage model is decreased, versican is still found in a few areas including the joint interzone 
and perichondrium. The presence of versican along with hyaluronan in the interzone could 
further joint interzone formation, the process of which is still not completely understood. 
Previous studies showed that the hyaluronan degratory enzyme, hyaluronidase 2 (Hyal-2), was 
up-regulated in the developing joint by overexpression of the hyaluronan-binding G1 domain of 
versican, suggesting a role for versican in regulation of hyaluronan metabolism during early 
stages of synovial joint morphogenesis.  The goal of this study was to manipulate versican and 
hyaluronan expression in the embryonic chick to obtain a better understanding of their 
interaction during synovial joint development. To study versican’s function, an adenovirally-
  
encoded G1 N-terminal hyaluronan-binding domain was over-expressed via microinjection into 
the presumptive elbow joint of embryonic chicks. To examine the potential interaction of 
versican with the hyaluronan pathway during joint development, microinjection of dominant 
negative CD44 adenovirus, the hyaluronan synthesis inhibitor 4-methylumbelliferone, and two 
hyaluronidase2 shRNA viruses (hyal2-702 and hyal2-1130) with or without co-injection of 
adeno-G1 versican was performed. After injection, changes in expression of hyaluronan were 
observed via histochemistry at early cavitation stages (HH35/36).  Morphological changes in the 
developing joint were observed using whole mount Alcian blue histochemistry and 
histochemical/immunocytochemical examination of tissue sections. To investigate whether 
adeno-G1 versican effects were dependent on hyaluronan or CD44, hyaluronan ELISA was 
performed to assess its accumulation due to up-regulation of Hyal-2. Overexpression of versican 
G1 in the developing synovial joint led to an enlargement of the interzone area and increased 
hyaluronan staining was seen in areas of adeno-G1 infection within treated limbs in comparison 
to controls. Treatment with 4-methylumbelliferone in conjunction with adeno-G1 also resulted in 
an increased interzone area but an overall decrease in hyaluronan accumulation. Hyaluronan 
ELISA results demonstrated reduced hyaluronan levels in the 4-methylumbelliferone treated 
samples in comparison to adeno-G1 alone. Immunohistochemical/histochemical staining along 
with trends seen from real-time PCR analysis of Hyal-2 suggests that the ability of G1 versican 
overexpression to upregulate Hyal-2 is dependent on hyaluronan.  
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1. INTRODUCTION 
Limb Development 
Limb development is an unresolved research question in biology. The chick limb bud 
begins to form about 3 days into development, also known as HH17 (Hamburger and Hamilton 
1951). From HH17 until HH21 the developing limb includes an accumulation of mesodermal 
cells that are very uniform morphologically; these cells are surrounded by ectoderm (Knudson et 
al., 1985). The next stage occurs as cell condensation takes place and mesodermal cells pack 
together and differentiate into chondrocytes. The condensation of pre-cartilage mesenchymal 
cells is a necessary process for overall chondrogenesis in the developing vertebrate limb and 
these cells undergo aggregation in a proximal to distal direction (Hall and Miyake, 1992, 2000; 
Shepard et al., 2007).  While this condensation of mesenchymal cells is taking place, increased 
levels of versican, tenascin, fibronectin, and other cell surface and ECM molecules are expressed 
(Hall and Miyake, 1992; Snow et al., 2005; Shepard et al., 2007; Choocheep et al., 2010). 
Aggregated mesenchymal cells are led to differentiate into chondrocytes by BMPs (bone 
morphogenetic proteins) and other growth factors, such as GDF-5 and TGF-β (Choocheep et al., 
2010). Different genes have been found to play roles in chondrogenesis including Sox9; a study 
performed in mouse embryos found that Sox9 expression was upregulated before and during 
chondrogenesis and if interrupted, mutations involving the Sox9 gene led to skeletal 
deformations and dysplasia (Foster et al., 1994; Wagner et al., 1994; Bell et al., 1997; Ng et al., 
1997). Collagen type II has also been identified as a large component of cartilage that helps to 
maintain the overall structure and is regulated by Sox9 (Bell et al., 1997; Ng et al., 1997). 
Aggrecan, a chondroitin sulfate proteoglycan, is also a major component and has the ability to 
bind and interact with hyaluronan (Hardingham et al., 1972; Knudson et al., 2001) which gives 
2 
 
hyaline cartilage its characteristic properties. The actual onset of synovial joint development 
occurs when the interzone begins to appear. This interzone has three layers, two outer layers near 
the future epiphyseal ends of long bone rudiment, which will contribute to the articular cartilage 
of the opposing proximal and distal ends, and a third layer that is a thin intermediate zone which 
will eventually form the fluid-filled synovial cavity (Ito and Kida, 2000; Guo et al., 2004; 
Pacifici et al., 2005). Interzone formation is characterized by the grouping and flattening of 
mesenchymal cells (Pacifici et al., 2005). Different growth factors, signaling molecules, 
transcription factors and other regulatory molecules are expressed during the formation of the 
interzone including several members of the Wnt family such as Wnt-9a, Wnt-16, and Wnt-4 that 
transduce their signals through the canonical Wnt pathway (Guo et al., 2004).  
The next step in joint development is cavitation; this occurs when the proximal and distal 
region of the forming joint separate and the synovial cavity is formed. The cavitation process has 
been linked to the accumulation of hyaluronan and one of its cell surface receptors, CD44.  
Hyaluronan and CD44 are thought to destabilize tissue integrity of the central interzone and lead 
to the actual separation of the joint sides (Craig et al., 1990; Archer et al., 1994; Edwards et al., 
1994; Pitsillides et al., 1995). Knockout of HAS2, a major hyaluronan synthase, in a mouse 
model resulted in deformed limbs as well as malformed or absent joints, implicating 
hyaluronan’s importance in joint cavitation (Matsumoto et al., 2009). Joint morphogenesis is 
another process that occurs following cavitation and is the least understood. During 
morphogenesis the two sides of the separated joints are shaped and able to interlock after the 
process is complete. The interlocking shapes are formed when the distal side starts to obtain a 
convex shape and the opposing proximal side becomes concave (Pacifici et al., 2005). By the end 
of synovial joint morphogenesis, the entire joint capsule has formed, including the fluid-filled 
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synovial cavity and the articular cartilages. Versican, a large chondroitin sulfate proteoglycan, 
has been found to play an important role during early stages of skeletal formation and continues 
to be expressed within articular cartilage and synovial tissue after morphogenesis is complete 
(Snow et al., 2005; Shepard et al., 2007). 
 
Versican 
Versican is a chondroitin sulfate proteoglycan of the hyalectin family found within the 
extracellular matrix (ECM). Versican is expressed constitutively in adult tissues such as the 
heart, blood vessels, and brain and transiently in developing tissues such as hair follicles, 
developing heart, and pre-cartilage mesenchymal condensations of the limb skeletal primordium 
(Bode-Lesniewska et al., 1996; Kimata et al., 1984; Shimomura et al., 1990; Snow et al., 2005; 
Williams et al., 2005; Choocheep et al., 2010). The transient expression of versican within areas 
where cells are accumulating suggests that this molecule is an important factor in cell 
aggregation that will eventually lead to tissue morphogenesis (Choocheep et al., 2010; Williams 
et al., 2005; Shepard et al., 2008). The ECM assists in control of cell behavior and phenotype 
during limb chondrogenesis (Shepard et al., 2007; Knudson et al., 1985) and evidence suggests 
that versican participates in these activities. Based on studies of versican expression patterns and 
effects on cell behavior in vitro, versican is believed to regulate the function of ligands within the 
ECM that may control signaling leading to cartilage development and synovial joint formation 
(Snow et al., 2005; Shepard et al., 2007; Choocheep et al., 2010). Many studies have supported 
the idea that versican can interact with other extracellular matrix molecules, such as fibronectin, 
to allow individual cells to come together to form aggregates (Williams et al., 2005; Kamiya et 
al., 2006; Choocheep et al., 2010). Versican has also been reported to participate in other 
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important morphological processes including cell migration, differentiation, and proliferation 
(Yamagata 1989, Zhang et al., 1999; Zhang et al., 1998; Zhang et al., 2001).  
Versican contains three different domains, G1, G2, and G3. The N-terminal G1 domain 
includes an immunoglobulin-like repeat followed by two link protein-like motifs necessary for 
interactions with hyaluronan (Kimata et al., 1986; Zimmerman and Rouslahti, 1989;  Ang et al., 
1999; Yang et al., 1999; Zhang et al., 1999). The G2 domain is comprised of two chondroitin 
sulfate glycosaminoglycan attachment regions (GAG-α and –β) encoded by differentially spliced 
exons that produce four isoforms, V0-V3. The third domain, G3, consists of two EGF repeats, a 
C-lectin like region and regulatory motif that appears important for cell and matrix interactions 
(Wu et al., 2005).  
The V0-V3 isoforms formed from alternative splicing of GAG-encoding domains are 
found within different tissues (Shinomura et al., 1993). The V0 isoform contains both GAG-α 
and -β regions. The V1 isoform includes only the GAG-β attachment region while the V2 
isoform consists of only GAG-α. The V3 isoform only contains the G1 and G3 domains of 
versican and does not contain either GAG attachment region (Zimmerman and Rouslahti, 1989; 
Zako et al., 1995). The V0-V3 isoforms have been identified in tissue specific locations and may 
control cell behavior during migration and adhesion (Kimata et al., 1986; Zimmerman and 
Rouslahti, 1989; Zako et al., 1995). The V0/V1 isoforms are widely expressed including 
appearance in appendicular precartilage condensations and interzone of presumptive synovial 
joints (Snow et al., 2005; Capehart 2010).  The V2 isoform is expressed predominantly in the 
nervous systems; however, the V3 isoform has not been detected as a protein (Choocheep et al., 
2010) and there is still little known regarding its expression or function in the developing limb 
(Hudson et al., 2010). 
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The primary focus of this study was to overexpress the G1 domain of versican and study 
its effects on synovial joint formation in the chick embryo, especially within the interzone of the 
developing elbow joint.  Our hypothesis was that joints injected with adeno-G1 versican would 
result in an overall enlargement of interzone area due to an increased accumulation of 
hyaluronan due to upregulation of the G1-domain. In a previous study, versican was localized 
within the interzone and epiphyses of the chick synovial joint supporting the idea that versican 
plays a part in formation and/or maintenance of the joint interzone (Shepard et al., 2007; 
Nagchowdhuri et al., 2012). Versican has also been located in the epiphyseal ends of long bones 
and perichondrium (Shinomura et al., 1990; Yamamura et al., 1997; Shepard et al., 2007) of the 
chick as well as within the presumptive joints of mice (Shibata et al., 2003; Snow et al., 2005). 
Additional evidence has been provided that suggests versican plays a role in adhesion and 
migration due to the pericellular matrix that is formed around the cell by interaction with 
hyaluronan (Wu et al., 2005). Indeed a recent study involving knockdown of versican within the 
chick synovial joint resulted in significant decreases in interzone area suggesting that versican is 
involved in creation and/or maintenance of this tissue (Nagchowdhuri et al., 2012). Additionally, 
versican-G1 overexpression within the developing chick elbow has revealed upregulation of 
several hyaluronan pathway genes, including the hyaluronidase, Hyal-2 (Vick 2012), so it was 
important to determine if G1-mediated upregulation of Hyal-2 was dependent on hyaluronan 
and/or CD44. Evidence of proteolyzed versican during synovial joint formation was found in 
mouse limbs during a recent study (Capehart 2010). This proteolyzed versican may allow 
versican fragments containing the G1 domain to be freed from the intact proteoglycan in the 
ECM that could further participate in joint development. In addition, versican has been shown to 
be co-localized with hyaluronan during early interzone formation which suggests that hyaluronan 
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may interact with versican’s G1 domain (Matsumoto et al., 2003; Capehart 2010). Concomitant 
with the ability to bind hyaluronan, V0/ V1 versican may provide a mechanism that aids 
accumulation of hyaluronan in close association with the cell membrane that could create a 
stable pericellular matrix and contribute to cell adhesion and/or interzone stability during the 
earlier stages of limb development (Capehart 2010). When cell separation begins during 
cavitation of the joint interzone there is also an increased accumulation of hyaluronan. It is 
possible but still unclear if versican cleavage and presence of the resulting G1-containing 
fragment has the capability of releasing hyaluronan from its usual CD44-mediated association 
with the cell surface and other ECM molecules (Capehart 2010) or if it facilitates hyaluronan 
interaction with CD44 or perhaps other hyaluronan receptors. This interaction of versican with 
hyaluronan and CD44 may be important for synovial joint formation.  
 
Hyaluronan 
Hyaluronan, a large non-sulfated glycosaminoglycan, can be found in the pericellular and 
extracellular space of most vertebrate tissues (Knudson et al., 2002; Kultti et al., 2009). 
Synthesis of hyaluronan and its degradation are believed to play a crucial role in joint cavity 
formation and have been shown to help establish and maintain spaces during embryonic 
development (Pratt et al., 1975; Pitsillides et al., 1995). This glycosaminoglycan contains 
charged residues that allow it to host many water molecules and also enables it to occupy a large 
amount of space (Sherman et al. 1994). In conjunction with other ECM components, such as 
aggrecan, hyaluronan can carry out many functions including formation of the basic structural 
unit of cartilage and may serve as a lubricant in synovial fluid (Sherman et al. 1994).  
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Hyaluronan can work concomitantly with cell surface receptors to promote important 
processes such as cell proliferation, migration, and intracellular signaling (Sherman et al., 1994; 
Li et al., 2007). The ability of these functions and others is dependent on degradation and 
regulation of hyaluronan synthesis (Sherman et al. 1994). Hyaluronan is synthesized in the 
plasma membrane via three different synthases, HAS1, 2, and 3. HAS2 has been shown to be the 
most important and is expressed in the vertebrate limb (Knudson 2003; Li et al., 2007). These 
synthases use UDP sugars as substrates to couple glucuronic acid and N-acetylglucosamine into 
a linear polymer (Kultti et al., 2009).). UDP-glucose is converted by uridine diphosphoglucose 
dehydrogenase (UDPGD) into the UDP-glucuronate required for the synthesis of hyaluronan 
(Pitsillides et al., 1995).  
Before pre-cartilage condensation occurs in limb morphogenesis, cells are surrounded 
with an extensive ECM where hyaluronan is the main glycosaminoglycan present (Knudson et 
al., 2001). The overall amount of hyaluronan synthesized before the condensation event is 
increased compared to the amount seen during differentiation of these mesodermal cells 
(Knudson et al., 1985; Shambaugh et al., 1980; Toole 1972). This decrease in hyaluronan along 
with increased expression of other ECM/cell surface factors could be responsible for 
condensation in the developing limb. Hyaluronan was also found along the joint line during the 
time when cavitation first occurs using a biotinylated hyaluronan-binding region link-protein 
complex (Craig et al., 1990; Pitsillides et al., 1995) supporting the idea that hyaluronan could be 
made and secreted into presumptive joint space (Oster et al., 1985; Laurent 1989). These studies 
also supported the idea that the absence of collagen in the presumptive cavity could possibly 
allow hyaluronan to achieve its swelling potential. Studies have shown that a higher UDPGD 
activity exists in the interzone area prior to and throughout separation of the cartilaginous 
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elements. In addition, levels of hyaluronan synthase were also higher in these areas. This 
increase in activity of both UDPGD and hyaluronan synthase suggest that the cells lining sites of 
joint cavitation have the ability to increase hyaluronan accumulation and this could be pertinent 
for synovial joint formation (Pitsillides et al., 1995). A recent study that knocked out the HAS2 
gene in mice resulted in a variety of phenotypes with extremely distorted limbs as well as defects 
in synovial cavity formation which further supports the importance of hyaluronan in overall limb 
development (Matsumoto et al. 2009). It is believed that hyaluronan is responsible for 
encouraging joint cavitation to occur via cell separation due to an action involving saturation of 
the hyaluronan receptor, namely CD44 (Toole 1991; Edwards et al., 1994; Pitsillides et al., 1995; 
Dowthwaite et al., 1998; Dowthwaite et al., 2003).  
 
CD44 
Joint interzone formation has been shown to be concomitant with an increase in synthesis of 
hyaluronan and also with elevation of hyaluronan-binding proteins such as CD44 (Craig et al., 
1990; Edwards et al., 1994; Pitsillides et al. 1995; Dowthwaite et al., 1998; Dowthwaite et al., 
2003). CD44 is a cell-surface glycoprotein that can exist in numerous isoforms via differential 
alternative splicing; currently several dozen isoforms are well known and all of them contain an 
amino terminal domain similar to cartilage link proteins (Bajorath et al., 1998; Naor et al., 2003). 
CD44 is capable of interacting with many extracellular and cell-surface ligands, the most 
important and most relevant to this study is hyaluronan (Naor et al., 2003). One possible reason 
for the interaction of hyaluronan with CD44 could possibly be to anchor the cells to the ECM. 
CD44 is a hyaluronan receptor that mediates systemic uptake and degradation of hyaluronan 
(Knudson et al., 2002). However, the ability of CD44 to actually bind hyaluronan is strictly 
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regulated since CD44 can exist in an inactive (non-binding) form and an active (binding) form 
(Isacke et al., 2002). The conversion of active or inactive forms is determined by changes in 
CD44 glycosylation, clustering in the plane of the membrane, modulation by the cytoplasmic 
domain, and insertion of variant exons (Isacke et al., 2002). There are at least four functional 
CD44 domains that can be described, extracellular distal, extracellular proximal, transmembrane, 
and intracellular domains. The extracellular domain of CD44 can undergo both O-linked and N-
linked glycosylation and is also subject to the addition of chondroitin sulfate side-chains (Isacke 
1994). The extracellular distal domain of CD44 consists of four basic amino acids that are 
important for the ability to bind hyaluronan (Bajorath et al., 1998; Knudson et al., 2002). CD44’s 
extracellular proximal domain is the main location for addition of glycosaminoglycan side chains 
and the main area where alternative splicing variation among the different isoforms occurs 
(Knudson et al., 2002). The transmembrane domain of CD44 is similar to most single-pass 
plasma membrane proteins and accessory proteins within the lipid bilayer or associated lipids 
could control the functionality of CD44 (Isacke 1994; Liu and Sy 1996; Knudson et al., 2002). 
The associations of cytosolic proteins within the 70-amino acid intracellular domain of CD44 are 
believed to be responsible for the cellular control of CD44 function (Knudson et al., 2002). 
CD44 is believed to play an important role in cell adhesion and migration events and has also 
been found to be an important factor during synovial joint formation (Isacke et al., 2002). Before 
the cavitation process occurs, the interzone area and future articular surfaces express CD44. 
Within the articular surfaces there is UDPGD activity and expression of HAS and other HAS-
associated molecules. However, in the interzone area there is very little UDPGD activity but 
there is unbound or free hyaluronan present. Once cavitation has occurred, the formed cavity is 
largely composed of free hyaluronan. The synovium and articular surfaces bind hyaluronan and 
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express CD44; these two areas also maintain HAS expression and UDPGD activity (Dowthwaite 
et al., 2003). Overall, the interaction of CD44 and hyaluronan plays crucial roles in events such 
as cell adhesion, de-adhesion, creation of cell-free spaces, and regulation of cell migration; 
however, there are still questions regarding signaling regulation and if these mechanisms are also 
used to regulate binding of this protein to other ECM ligands or in other CD44-mediated cell:cell 
interactions (Isacke 1994; Sherman et al., 1994). There are also still mysteries regarding CD44 
participation in degradation of hyaluronan even though anti-CD44 monoclonal antibodies are 
capable of blocking uptake of hyaluronan but the rate and amount of hyaluronan internalization 
are not always consistent with a receptor-mediated mechanism (Isacke 1994).  
 
Hyaluronidase 2  
Hyaluronidases are important factors for catabolism and degradation of hyaluronan. The Hyal-2 
gene has been shown to be involved in many activities including embryonic development but 
there is still little known regarding its regulation (Lepperdinger et al. 2001; Chow et al. 2005). 
Hyaluronidases are representative of a family of β-endoglucosidases that cleave internal β-1, 4 
linkages resulting in the degradation of hyaluronan (Chow et al., 2006). There have been several 
hyaluronidase genes found in humans organized in groups of three at two different chromosomal 
locations (Csoka et al., 2001; Chow et al., 2005; Chow et al., 2006). Hyal-2 is found on the 
3p21.3 chromosome along with Hyal-1 and Hyal-3 (Chow et al., 2005; Chow et al., 2006). Hyal-
1 and Hyal-2 are the most important mammalian hyaluronidases within somatic tissues (Csoka et 
al., 2001; Knudson 2003) and are believed to work together to degrade hyaluronan (Csoka et al., 
1999; Chow et al., 2006). Cartilage has been known to express Hyal-1, Hyal-2, and Hyal-3 
transcripts (Flannery et al., 1998; Chow et al., 2005). The Hyal-2 gene has the ability to 
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hydrolyze hyaluronan into smaller fragments and is primarily found in lysosomes, giving this 
hyaluronidase interesting substrate specificity; the most efficient activity of this hyaluronidase 
occurs at a pH of 4.0 (Lepperdinger et al., 1998; Chow et al., 2006). A study using chick embryo 
fibroblasts found two hyaluronidase enzymes, cell associated and medium associated forms 
(Orkin et al. 1980). These enzymes appear to be lysosomal and it is believed that they are 
initially transported from the Golgi apparatus to the plasma membrane where they are 
reinternalized or secreted (Neufeld et al. 1977; Orkin et al. 1980). This suggests that the 
hyaluronidase is subjected to a neutral pH then integrated into a more acidic pH in the secondary 
lysosome (Orkin et al. 1980b). The secreted hyaluronidase is more stable at a neutral pH, unlike 
the intracellular form which is stable at lower pHs, possibly due to the presence of sialic acid 
(Orkin et al., 1980a).  
There is evidence supporting a two-step process to intracellular hyaluronan degradation. 
First, hyaluronan is broken down from its large mass into smaller fragments by Hyal-2 at the cell 
surface and transported to lysosomes where Hyal-1 and β-glucuronidase and β-N-
acetylglucosaminidase will continue the degradation process (Stern 2003). However, in an 
embryonic study involving Xenopus laevis there is a Hyal-2-like hyaluronidase both attached to 
the cell surface and intracellular; the cell surface Hyal-2 was attached via a GPI-anchor and 
degradation of hyaluronan occurred at both normal physiological and a more acidic pH 
(Mullegger et al., 2002). Another study also found evidence that Hyal-2 works intracellularly by 
locating recombinant C-terminal and N-terminal tagged Hyal-2; the C-terminus would not have 
been seen if a C-terminal cleavage had occurred in order to transfer the Hyal-2 to a GPI-anchor 
(Chow et al., 2006).  Studies have shown that chloroquine, a lysosomotropic agent, blocks the 
degradation of hyaluronan into small pieces by chondrocytes (Hua et al., 1993; Chow et al., 
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2005). This blockage indicates that hyaluronan is catabolized intracellularly via lysosomal 
hyaluronidases (Chow et al., 2005).  There are clearly still unsettled issues regarding whether 
Hyal-2 functions intracellularly or on the cell surface; this could be dependent on state of 
development, and possibly cell type. 
 
Experimental Objectives 
In a recent study, a proteolyzed fragment of versican containing the G1 domain of 
versican was localized to the developing joint at stages immediately preceding and during 
cavitation (Capehart 2010), therefore, it was important to determine if the G1 domain of versican 
has biological activity during joint formation that could be demonstrated by adenoviral-mediated 
overexpression in vivo. Since recent microarray and real-time PCR work in our lab demonstrated 
upregulation of Hyal-2 due to overexpression of G1-versican in developing chick joint tissues 
(Vick 2012), it was also of interest to investigate the means by which Hyal-2 upregulation 
occurred. As versican, hyaluronan, and CD44 have all been found co-localized in the embryonic 
joint (Wu et al. 2005) and all appear to play important roles in joint formation we decided to 
investigate if G1-mediated upregulation of Hyal-2 was dependent on hyaluronan and/or CD44. 
In order to determine if G1-mediated signaling was dependent on hyaluronan, 4-
methylumbelliferone was co-injected with an adenoviral-G1 domain construct. To determine if 
signaling was dependent on CD44, an adenovirus encoding a tailless CD44 that blocks wild-type 
CD44 hyaluronan interactions was co-injected with adeno-G1. Whole mount and histochemical 
staining of tissue sections in addition to real-time PCR, hyaluronan zymography, and hyaluronan 
ELISA were utilized in order to draw conclusions regarding how G1 versican-mediated signaling 
may occur. 
  
2. METHODS 
 
Embryos 
Eggs (Charles River) used were viral-free and fertilized. Eggs were kept in a humidified 
incubator at 37.5°C until experimental treatment and subsequent harvest for analysis (AUP 
approval letter, Appendix A). Embryos were removed at HH 35/36 (day 9 or 10). After removal 
of membranes and rinsing embryos with phosphate buffered saline (PBS) they were fixed 
immediately in 4% paraformaldehyde. 
 
Adenoviruses and Chemical Reagents 
Replication incompetent recombinant adenoviruses (Adeno-X System, Clontech) were utilized 
for microinjection and used as a vector to transfer DNA to target cells of the chick limb in ovo. 
Genes needed to replicate the virus were removed and replaced with  a cloning site that allowed 
insertion of recombinant DNA encoding the G1 versican domain or other constructs. When 
viruses bind to an integrin and are internalized, constitutive viral expression is regulated by the 
cytomegalovirus (CMV) promoter. Versican adenoviruses used in this study consisted of a C-
terminal hemaglutinin (HA)-tagged murine G1 domain produced using bases 154-1219 
(NM_001081249; Kern et al., 2007; Hudson et al., 2010). LacZ encoding adenovirus was also 
used in conjunction with adeno-G1 to aid in rapid identification of infected tissues (Kern et al., 
2007; Hudson et al., 2010). In addition to lacZ and G1 viruses, microinjection with dominant 
negative adeno-CD44 (DN-CD44) (a kind gift provided by the Knudson lab) and also two hyal2 
shRNA-encoding viruses (hyal2-702 and hyal2-1130), targeting HYAL-2 (XM 4142580) bases 
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GCAACTCTGGGGGTATTAC and TCAAGGATTATATGGAAGG respectively, were used to 
examine if disruptions in joint development or hyaluronan localization occurred.  
Selected embryos were also injected with 4-methylumbelliferone in combination with 
adeno-G1 versican. Four-methylumbelliferone (4-MU) has been shown to inhibit hyaluronan 
synthesis since active glucuronidation of 4-MU creates large amounts of 4-MU-glucuronide 
resulting in the decrease of the cellular UDP-GlcUA pool (Kultti et al., 2009). Studies have also 
shown that 4-MU may target HAS substrate, HAS2, and possibly HAS3 (Kultti et al., 2009).  
 
Microinjections 
Eggs at 4.5 days (HH25) of incubation were cleaned using 70% ethanol, and “windowed” by 
removal of a small portion of the egg shell to gain access. The overlying vitelline membrane was 
carefully peeled away using a tungsten needle. The embryo develops on its left side which leaves 
the right wing exposed. The right limb was positioned and injected with recombinant 
adenoviruses using a pneumatic picopump (PV820 World Precision Instruments). The injection 
was performed by positioning the microinjection capillary needle at an approximately 45° angle 
anterior to the center of the wing bud. Once the capillary needle was in position the needle was 
inserted and approximately 1.0μL of adenovirus solution was injected. Injections of G1-
adenovirus (9.0x10
9
 ifu/ml) and DN-CD44 adenovirus (5x10
9 
ifu/ml) were performed in a 1:1 
ratio with lacZ adenovirus (5.3x10
9 
ifu/ml) so that β-galactosidase staining could be used to 
monitor infection site. Other viruses and reagents used included the two hyal2 shRNA viruses 
(5.0x10
9
 ifu/mL) and 4-methylumbelliferone. Four-methylumbelliferone (Sigma) was prepared 
at 2mM concentrations in PBS and sterilized using a 0.22µM non-pyrogenic syringe filter. Four-
methylumbelliferone was co-injected with adenoviral constructs in equal amounts yielding final 
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concentrations of 0.5-1.0 mM dependent upon combinations utilized (adeno-G1 or adeno-
G1&lacZ). Once injected, eggs were sealed with tape and returned to the incubator until the 
desired stage of development (HH35/36, 9 or 10 embryonic days).  
 
Whole Mount Alcian Blue Staining 
Whole mount Alcian blue staining was used to view gross morphological changes in limbs of 
chick embryos using a modification of Kuczuk and Scott (1984). When harvested, embryos were 
fixed in 4% paraformaldehyde for 40 minutes and washed in PBS before placing in 95% ethanol 
overnight. The next day embryos were placed in Alcian Blue stain (Sigma; prepared as 80mL 
95% ethanol, 20mL glacial acetic acid, 15mg Alcian Blue, filtered before use) overnight at room 
temperature and rocked gently. Embryos were then rinsed twice with 95% ethanol for 1 hour 
each to remove remaining Alcian Blue. After rinsing, embryos were macerated in 2% potassium 
hydroxide until the entire skeletal template was visible (approximately 2-4 hours). Once the 
skeleton was visible, embryos were placed in KOH: glycerin solutions for 1 hour each (80:20, 
60:40, 40:60, and 20:60). Embryos were then stored in 70% glycerol/ 30% PBS.  
 
Whole Mount X-gal Staining 
Whole mount X-gal staining was used to localize sites of adenoviral infection (Kern et al., 2007). 
Embryos were harvested, fixed in 4% paraformaldehyde for 40 minutes and washed 3 times 5 
minutes each with cold PBS. Embryos were then washed 3 times for 5 minutes each in cold 
permeabilization buffer (0.02% Na-deoxycholate, 0.01% NP-40 in PBS) and left on a rocker 
overnight at 4°C in order to minimize background. Embryos were stained with X-gal 
(Invitrogen) or RedGal (Research Organics) stain (0.1% K-ferricyanide, 0.1% K-ferrocyanide, 
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0.02% MgCl2, 0.1% X-gal/Red Gal made in dimethyl formamide at 100 mg/.ml in PBS) at 37°C 
in the dark. The stain (blue or red) was usually visible within 1.5-4 hours. When staining was 
complete, embryos were post-fixed in 4% paraformaldehyde for no longer than 30 minutes and 
then stored in 70% ethanol until ready to progress with the embedding procedure the next day. 
 
Statistical Analysis 
Pictures of Alcian Blue stained samples were taken using digital photo-microscopy at low power 
under a dissecting microscope (Olympus SZ-60) using SPOT-RT camera (Diagnostic 
Instruments) and software. Measurements of interzone area of each sample were taken using 
Image-J software (NIH) and a Student’s t-test performed with significance set at p<0.05 (Hudson 
et al., 2010). Comparison of control un-injected contralateral limbs was used to test the 
hypothesis of this study which was that there would be an enlargement of interzone space in the 
adeno-G1 treated limbs. 
 
Immuno-& Histochemical Staining 
Sections were dehydrated, embedded in paraffin wax, and sectioned at 7-8 micrometers. Mouse 
anti-hemaglutinin IgG (H3663, Sigma) was used at 3.3μg/ml (1:100) to detect the C-terminal tag 
located on the recombinant G1-domain adenovirus. Biotinylated hyaluronic acid binding protein 
(Cape Cod) at 2.5 μg/ml (1:200) was used to detect hyaluronan and examine impacts of versican 
G1-domain overexpression on its localization. Double labeling of target molecules was used 
during staining procedures when possible. Paraformaldehyde-fixed sections were de-waxed and 
subjected to antigen unmasking using a citric acid formula at high temperature (Biocare Medical 
decloaking chamber) for 20 minutes (Snow et al., 2005; Hudson et al., 2010). All samples were 
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then incubated in 0.25U/ml chondroitinase ABC (Sigma) in PBS for at least one hour at 37°C. 
Sections were blocked with 3% bovine serum albumen and 1% goat serum in PBS for one hour 
and incubated with primary immunoreagents overnight at 4°C. Sections were washed with PBS 
and incubated with FITC-conjugated secondary antibodies (Cappel; 1:400) or TexasRed 
Streptavidin (Vector labs; 1:200) for up to two hours at room temperature. All secondary 
reagents were diluted in blocking buffer (3% bovine serum albumen and 1 % goat serum in 
PBS). In order to control for potential non-specific staining of secondary reagents, primary 
antibodies were omitted from selected sections in each experiment (Appendix B). Sections were 
washed in PBS and post-fixed in 80% and 50% ethanol 5 minutes each. Sections were re-
equilibrated in PBS and mounted in DABCO (Sigma) anti-fading agent (10% 1X PBS, 90% 
glycerol, 100mg/mL DABCO) to retard fading of fluorescence (Hudson et al., 2010). All 
sections were stored at 4°C in the dark. 
 
Protein Extractions 
Chicks at HH35/36 were harvested and rinsed with PBS and elbow joints were dissected. 
Injected elbow joints were pooled, placed in separate centrifuge tubes and kept in cold PBS. The 
same was done with contralateral control elbow joints. A glass mortar and pestle was used to 
grind the tissue samples in a mixture of protein extraction buffer (M-PER, Thermo Scientific) 
containing protease inhibitor cocktail (Sigma). This was done separately for each sample pool 
and supernatant was removed and placed in a new centrifuge tube placed on ice for 30 minutes. 
Lysates were clarified by centrifugation at 10,000 X g for 10 minutes, supernatants removed, 
placed in a new tube, and frozen at -80°C until ready for assay. All samples were assayed for 
protein content using a Micro BCA
TM 
Protein Assay Reagent Kit (Pierce).  
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Hyaluronan Zymograms 
Activity of hyaluronidase within embryonic chick elbow lysates was assayed using hyaluronan 
zymography. For this study, zymograms were performed at pH 3.7 and 5.0. Samples were 
normalized for protein content, separated on a 10% SDS polyacrylamide gel containing 0.17 
mg/mL hyaluronan (Genzyme, Framingham, MA) and incubated for 1 hour in 0.3% Triton X-
100. Gels were incubated overnight at 37°C in 0.1M sodium formate at pH 3.7 or pH 5.0, 
containing 0.15M NaCl. Once the overnight incubation was complete gels were treated with 1 
mg/mL pronase in 20 mM Tris HCL, at a pH of 8.0, for 1 hour. Gels were then stained with 
Stains All (MP Biomedicals) overnight. Next, the gel was de-stained using distilled water until 
bands could be visualized and background was reduced. Bands were imaged using the Fluor-S 
MultiImaging system (BioRad, Chow et al. 2006).  
 
Hyaluronan ELISA 
Elbow lysates were prepared from HH35 chicks as above following microinjection with selected 
adenoviruses. ELISA was performed using a DuoSet Assay Development kit (R&D Systems). 
Plates were prepared with a coating of diluted Capture Reagent (0.5 µg/mL in PBS), sealed, and 
left at room temperature overnight. The next day wells were aspirated and washed with kit Wash 
Buffer (0.05% Tween 20 in PBS at pH 7.2-7.4) three times. Plates were blocked using Block 
Buffer (5% Tween 20 in PBS, 0.05% NaN3) and incubated for one hour at room temperature. 
Another aspiration and wash series was performed three more times and protein samples were 
added to wells diluted in the Reagent Diluent (5% Tween 20 in PBS) and incubated for a total of 
two hours at room temperature. Another wash series was performed as above and Detection 
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Reagent (0.4µg/mL biotinylated recombinant human aggrecan in Reagent Diluent) was added 
and incubated at room temperature for another two hours. Wells were aspirated, washed again 
and Streptavidin-HRP was added to wells and incubated for 20 minutes at room temperature in 
the dark. Substrate Solution (1:1 ratio of color reagent A-hydrogen peroxide and color reagent B-
tetramethylbenzidine) was added to each well after another wash and incubated for 20 minutes at 
room temperature in the dark. Stop Solution (2N H2SO4) was added to each well and optical 
density determined using a microplate reader (Multiskan Ascent V1.25, Thermo Electron 
Corporation) at 450 nm and 540 nm. Readings at 540 nm were subtracted from the readings at 
450 nm in order to accommodate any optical imperfections on the microplates. To determine 
hyaluronan concentrations, a hyaluronan standard was analyzed and concentrations were 
determined based on the equation provided by the standard on a logarithmic chart as suggested 
by the protocol. 
 
RT-PCR 
Microinjections were performed as stated above and embryos harvested at HH35 (embryonic day 
9-9.5). Injections assayed were as follows: adeno-G1, co-injection of 4MU & G1, co-injection of 
hyal2 adeno-shRNA 702 & 1130, and co-injection of DN-CD44 & G1 adenoviruses, and an un-
injected contralateral control. RNA was extracted from elbow regions of injected limbs using the 
RiboPure Kit (Applied Biosystems). Reverse transcription was performed using oligodT priming 
of sample RNA using the Superscript III First Strand Synthesis Kit (Invitrogen).  The cDNA was 
normalized to equal concentration and used in RT-PCR. All RT-PCR reactions were carried out 
in a total of 15 µL containing 1µL of Forward and Reverse primers for Hyal-2, and β-actin at 
30µM, 1 µL cDNA template (1µL of ddH2O was used for negative controls), 4.5µL of ddH2O, 
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and 7.5µL of MasterMix. RT-PCR was performed in a thermocycler (Bio-Rad MyCycler) for 30 
cycles with initial denaturation  set at 95°C for 5 minutes, a second denaturation step set at 95°C 
for 30 seconds, annealing step set at optimal annealing temperature of 49°C for 30 seconds, and 
elongation step at 72°C for 45 seconds. Once cycles were completed another final elongation 
step was performed at 72°C for 10 minutes and amplicons held at 4°C. Products were analyzed 
on a 0.8% agarose gel using gel electrophoresis. Once the gel mixture was prepared and allowed 
to cool, 2 µL of ethidium bromide was added before pouring the mixture into a gel tray. Gels 
were electrophoresed for approximately 30 minutes at 135 V and viewed on an ultraviolet 
transilluminator to observe bands. Primers yielding amplicons of the predicted size (107 base 
pairs) were then used for real-time PCR.  
 
qRT-PCR of Hyal-2  
Based on RT-PCR results, the primer set used was HYAL2 F: 5’-CCTGGACTTCAGCGTCT-
3’, R: 5’-TGTAGTAGGGGTAGAGCC-3’. As a control, β-actin primers were used to amplify 
endogenous β-actin in samples (F: 5’-CACAGATCATGTTTGAGACCTT-3’, R: 5’-
CATCACAATACCAGTGGTACG-3’; Accession #L08165; DeBoever et al., 2008).  Reactions 
were carried out in a total volume of 10 µL and consisted of 1µL of the forward and reverse 
primers, 1µL cDNA template (1 µL of ddH2O was used for negative controls), 2µL ddH2O, and 
5 µL of 2X SensiFAST SYBR No-ROX Mix (BIOLINE). The qRT-PCR was carried out in a 
thermocycler (CFX96 Real-Time System, BioRad) for 41 cycles with the initial denaturation 
step at 95°C for 2 minutes, a second denaturation step at 95°C for 5 seconds, an annealing step at 
the optimal temperature of 49°C for 10 seconds, an elongation step at 72°C for 10 seconds, and 
an additional elongation step at 65°C for 5 seconds.  Three technical replicates were tested for 
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each adenoviral treatment indicated previously with two biological replicates represented due to 
low embryonic viability. Threshold cycle data was analyzed relative to control samples using MS 
excel, and Pfaffl (2001) analysis was used for relative quantification calculation. Student’s t-test 
was also performed to determine statistical significance of results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
3. RESULTS 
This study was undertaken to provide new information regarding the role of the G1 domain 
of versican and its interaction with hyaluronan during synovial joint formation, especially within 
the elbow interzone since there is still little known regarding ECM regulation of interzone 
dynamics. Recent studies showed that inhibition of versican expression within the developing 
chick joint led to decreases in interzone area (Nagchowdhuri et al. 2012) and that hyaluronan is 
crucial to the development of the synovial joint, especially in terms of spacing (Matsumoto et al. 
2009). Based on these reports, the present study hypothesized that there would be an overall 
enlargement of interzone area in developing wing joints injected with recombinant versican G1-
domain adenovirus in the presumptive joint region, resulting in alteration of elbow formation due 
to increased levels of versican-hyaluronan interaction.  
 Morphological effects in response to adenoviral-mediated overexpression of G1-versican 
domain in joints were gauged by whole mount staining of limbs using Alcian Blue 
histochemistry in concert with staining for the adeno-β-galactosidase reporter to aid localization 
of infected tissues. Histological examination of tissue sections and hyaluronan localization in 
regions of hemaglutinin-tagged G1 domain expression were used to evaluate effects of adeno-G1 
mediated over-expression on joint morphogenesis with higher resolution. 
Because recent microarray and real-time PCR experiments in our lab documented 
upregulation of Hyal-2 transcripts in response to G1-versican overexpression in developing 
joints, another aim of this study was to assess function and G1-mediated regulation of Hyal-2 
during the process of joint morphogenesis in the developing chick embryo. This study 
investigated versican G1-mediated signaling in order to determine if effects on Hyal-2 were 
dependent on hyaluronan and/or CD44.  In order to study these effects, presumptive joints were 
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treated with 4-methylumbelliferone and adeno-versican G1 followed by assay for changes in 
Hyal-2 mRNA via qRT-PCR. This was also tested by injecting embryonic limbs with a dominant 
negative-CD44 virus to block wild-type CD44-hyaluronan interactions in the presence of 
versican G1 over-expression. This study also sought to determine if a G1-mediated increase in 
Hyal-2 mRNA was reflected as an increase in hyaluronidase activity and if this activity was 
affected by a difference in pH using protein lysates of control and versican G1-treated chick 
elbow joints. Another method to investigate hyaluronidase function was knock-down of chick 
Hyal-2 using adeno-shRNAs to examine differences in activity and subsequent hyaluronan loss.  
 
Histochemical/Immunocytochemical Staining 
To identify the location of adenoviral infection, whole mount β-galactosidase staining was 
performed. Recombinant G1 in limbs that were injected with the adeno-G1 versican was 
immunolocalized with a C-terminal murine hemaglutinin tag.  Co-distribution of β-galactosidase 
staining along with G1-hemaglutinin tag expression was used as a reliable indicator of infection 
sites. Biotinylated hyaluronan binding protein (bHABP) was used to localize endogenous 
hyaluronan in the chick elbow joint at HH35/36 and to observe changes in hyaluronan in 
response to G1 domain overexpression. Distinct pericellular hyaluronan within the developing 
joint was co-localized with adeno-G1 versican  positive chondrocytes within forming articular 
cartilage areas in both adeno-G1 treated limbs and in limbs treated with 4-methylumbelliferone 
in conjunction with adeno-G1 versican (Figure 1 and 2). Hyaluronan staining appeared to have a 
more robust pericellular coat in areas where adeno-G1 was present. In samples treated with 
adeno-G1 there was a noticeable increase in hyaluronan accumulation within the injected limb 
versus the contralateral control (Figure 1). In limbs treated with both 4-methylumbelliferone and 
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adeno-G1 there was a slight decrease in overall hyaluronan accumulation in comparison to the 
untreated contralateral control limbs (Figure 2).  
 
Whole Mount Alcian Blue Staining 
To observe morphological effects of versican G1-domain manipulation, whole mount Alcian 
blue staining was performed and area measurements were taken of the interzone space between 
epiphyseal ends of the humerus, ulna, and radius using ImageJ software (Figure 3). 
Measurements were analyzed using Student’s t-test and overall data included averages of 
measurements from different embryo samples, standard deviations, and p-values of the interzone 
area of un-injected contralateral control limbs in comparison to the injected limbs (Table 1). 
There was an average increase of 23% in interzone area (space between humerus, ulna, and 
radius) resulting from infection with adeno-G1 versican in comparison to contralateral control 
(un-injected) limbs. Treatment with 4-methylumbelliferone in conjunction with adeno-G1 
versican resulted in an average increase of 23% of the interzone dimensions as well. DN-CD44 
adenoviral infection resulted in an increase of 41% interzone area. Infection with DN-CD44 in 
conjunction with adeno-G1 versican resulted in an increase in interzone spacing but results were 
not significant, however sample size was small due to lack of overall embryonic viability as a 
result of these co-injections. Results from co-injection of the hyal2 shRNA viruses (702 &1130) 
resulted in slightly increased spacing, but also insignificant. The original hypothesis that G1-
versican overexpression would cause enlargement in the interzone was supported. Differences 
between contralateral control and injected limbs of adeno-G1 versican alone, co-injection of G1-
versican with 4-MU, and DN-CD44 adenovirus were significant at p<0.05. Approximately 50% 
of adeno-G1 versican and 4-MU/G1-versican treated embryos that were viable post-injection 
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contained a measurable increase in interzone area. Approximately 86% of DN-CD44 treated 
embryos resulted in an increase in interzone area as well (Table 2).  
 
Hyaluronan ELISA 
To determine differences in concentration of hyaluronan between different adenoviral 
treatments, hyaluronan ELISA was performed on protein lysates of chick elbow joints at HH35 
and concentrations were determined using the hyaluronan standard provided with the Duo Kit. 
Although results were not significant based on Student’s t-test, trends were noticed among 
different samples (Figure 4). Lower levels of hyaluronan were found in embryonic limbs treated 
with 4-methylumbelliferone in conjunction with adeno-G1 versican in comparison to controls. 
Higher levels of hyaluronan were found in samples that were treated with adeno-DN-CD44 in 
addition to adeno-G1 versican. No major differences in hyaluronan concentration were noticed in 
treatments with Hyal-2 shRNAs, adeno-G1, and adeno-DN-CD44 treatment alone.  
 
Real-Time PCR 
 To observe changes in HYAL2 gene expression, RT-PCR and qRT-PCR were 
performed. Primers were checked using RT-PCR and once optimal temperatures and appropriate 
band sizes were verified they were used in qRT-PCR. Samples assayed included untreated 
control, 4-methylumbelliferone co-injected with the adeno-G1, adeno-G1 alone, DN-CD44 co-
injected with the adeno-G1, and the two Hyal-2 shRNA adenoviruses (Figure 5). Fold change 
calculations were based on Pfaffl (2001) and provided a means of normalizing all data to the β-
actin reference gene. All primers had a 100% efficiency based on the calculation using the 
formula E=10
(-1/slope) 
(Higuchi et al., 1993). To determine significance of results a Student’s t-test 
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was performed. Results were insignificant based on p-values but trends were visible among 
different samples. Four-methylumbelliferone in conjunction with the adeno-G1 versican showed 
a decrease in the relative fold change in comparison to untreated controls. Adeno-DN-CD44 in 
conjunction with adeno-G1 versican as well as adeno-G1 versican injected alone showed a slight 
increase in fold change in comparison to untreated controls. The two Hyal-2 shRNA 
adenoviruses were deemed unsuccessful in terms of ability to knockdown Hyal-2 levels due to 
the insignificant fold changes in Hyal-2 expression.  
 
Hyaluronan Zymography 
To investigate hyaluronidase activity and attempt to correlate that to Hyaluronidase-2 expression, 
hyaluronan zymograms were performed. Protein lysates of equal concentration from chick elbow 
joints at HH35 were used in this assay. Based on preliminary results, hyaluronidase activity was 
seen at 64 kD at pH 3.7. No activity was found approaching the more neutral pH of 5.0 (Figure 
6). No major differences in band intensities were seen in samples that were assayed. 
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Figure 1.  Immunohistochemical staining of sagittal sections of HH35 chick elbows in un-
injected control (A, C, E) and 5 days following adenoviral treatment with G1-versican (B, D, F, 
G). Panel B shows G1-hemaglutinin tag localization within the infected chick limb. More intense 
pericellular hyaluronan staining is noted in areas with G1-hemaglutinin tagged cells (arrows) 
relative to uninfected-cells showing pericellular hyaluronan staining (D). Panel F shows areas of 
infection indicated by β-galactosidase staining. Panel G is an overlay of the double-labeled 
hemaglutinin-tagged adeno- G1 versican and hyaluronan binding protein staining to further 
accentuate co-localization of hyaluronan-positive cells with sites of infection. Increased 
interzone spacing consistent with whole mount staining of G1-infected limbs can also be 
distinguished within the infected limb in comparison to the contralateral control along with 
increased hyaluronan staining overall (depicted by bracket). Scale bar = 50µM for all panels. h, 
humerus. u, ulna. 
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Figure 2. Immunohistochemical staining of sagittal sections of chick elbows at HH36  in 
contralateral control (A, C, E)  and following infection with adeno-G1 versican in conjunction 
with 4-methylumbelliferone at HH25 (B, D, F). Panel B indicates areas of hemaglutinin-tagged 
G1 cells within developing articular cartilage of the ulna (arrow). Panel D shows pericellular 
hyaluronan binding protein staining that is more robust in areas with G1-positive cells (arrow). 
Panels E and F are respective phase contrast images. An intense overall staining of hyaluronan 
was noticed in the contralateral control limb in comparison to the injected, depicted by large 
arrows (C, D). Scale bar = 50µM for all images. h, humerus. u, ulna. 
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Figure 3. Whole mount Alcian Blue staining of HH35/36 chick limbs depicting results of 
overexpression of adeno-G1 versican (A), adeno-G1 versican in conjunction with 4-
methylumbelliferone (B), and adenoviral infection with DN-CD44 (C). Treatments resulted 
in an increase in interzone space between epiphyseal ends of the humerus, ulna, and radius in 
comparison to contralateral controls (CLC). Red staining seen in panel C shows β-
galactosidase staining indicating area of adenoviral infection. Panel D depicts how 
measurements were taken with ImageJ software. All scale bars = 1.0 mm. 
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HA ELISA 
Figure 4. Hyaluronan ELISA assay results. Hyaluronan concentration was determined from 
absorbances and extrapolated from a standard curve. Statistical analysis was performed using 
Student’s t-test. All results were deemed insignificant (p>0.05). 
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Figure 5. Gene expression results of the Hyal-2 gene normalized with β-actin. Calculations were 
based on Pflaffl (2001) and statistical significance determined by Student’s t-test. All results 
were deemed insignificant (p>0.05). 
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Figure 6. Hyaluronan zymography results. Top image depicts hyaluronidase activity at pH 3.7. 
Bottom image depicts the lack of hyaluronidase activity approaching the more neutral pH of 5.0. 
Hyaluronidase activity bands were seen at approximately 64 kD, the molecular weight of Hyal-2. 
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Table 1. Estimates of chick embryo interzone areas in square-millimeters from Alcian Blue 
whole mount staining at HH35/36 following treatment at HH25. Mean matched-pair analysis 
was used to determine whether differences between average interzone area measurements of 
injected and contralateral control wings were statistically significant. *P-values < 0.05 were 
determined significant. 
 
Adenovirus(es) Injected Number of 
Viable 
Embryos 
at 
HH35/36 
Post-
Injection 
(n) 
CLC 
Interzone 
Area 
(mm2) 
Injected 
Interzone 
Area 
(mm2) 
% Increase 
in 
Interzone 
Area 
P-value 
G1 8 0.094 ± 
0.02 
0.122 ± 
0.02 
23% 0.00017* 
DN-CD44 6 0.091 ± 
0.03 
0.153 ± 
0.03 
41% 0.0017* 
4MU+G1 3 0.124 ± 
0.01 
0.162 
±0.01 
23% 0.012* 
DN-CD44+G1 3 0.124 ± 
0.01 
0.161 ± 
0.03 
13% 0.159 
Hyal shRNA 702+1130 3 0.097 ± 
0.02 
0.112 ± 
0.01 
23% 0.143 
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Table 2. Chick elbow joint phenotypes shown by morphological assessment of Alcian Blue 
whole mount staining at HH35/36 injected with G1-adeno versican, DN-CD44 adenovirus, and 
4-methylumbelliferone in conjunction with G1-adeno versican at HH25. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adenovirus(es) Injected 
 
Number of 
Viable Embryos 
Post-Injection 
Number of Viable 
Embryos with 
Increased 
Interzone Areas 
Percent of Viable 
Embryos with 
Phenotype 
G1 16 8 50% 
DN-CD44 7 6 86% 
4MU+G1 6 3 50% 
  
4. DISCUSSION 
Synovial joint formation is prefaced by the formation of the interzone, an area consisting 
of three layers that will create the articular cartilage and fluid-filled space of the synovial cavity 
(Ito and Kida, 2000; Guo et al. 2004; Pacifici et al., 2005). Versican, a chondroitin sulfate 
proteoglycan found within the extracellular matrix has been shown to participate in limb 
morphogenesis and is primarily localized within the interzone of the developing joint following 
initial chondrogenesis (Shepard et al. 2007). There has been recent evidence that individual 
domains of versican can function independently of the intact proteoglycan (Kern et al., 2007; 
Hudson et al., 2010). A recent study in the early stage murine interzone localized a proteolyzed 
versican fragment containing the G1 domain of versican that was co-distributed with the intact 
proteoglycan, ADAMTS-1, and hyaluronan (Capehart 2010). Localization of this proteolyzed 
fragment, DPEAAE (the neoepitope sequence resulting from cleavage of versican by ADAMTS-
1), showed that the G1 domain can be freed from the intact proteoglycan and may participate in 
further synovial joint formation (Capehart 2010).  
The purpose of this study was to investigate the function of the G1 domain of versican 
and, in addition, determine how G1 overexpression within the developing joint leads to 
upregulation of Hyaluronidase-2 as noted in previous microarray and qRT work from the lab. 
Specifically, we wanted to distinguish if effects of G1 versican overexpression on Hyal-2 were 
dependent on hyaluronan or its major cell receptor, CD44, since both have been identified as 
playing roles in synovial joint formation (Craig et al., 1990; Archer et al., 1994; Edwards et al. 
1994; Pitsillides et al. 1995; Dowthwaite et al., 1998; Matsumoto et al., 2009). Previous work 
showed that versican interacts with hyaluronan and CD44, and all are localized within the 
developing joint (Wu et al., 2005). To study versican interaction with the hyaluronan pathway, 
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replication deficient adenoviruses overexpressing the G1 domain of versican or a DN-CD44 
adenovirus, along with 4-methylumbelliferone (a hyaluronan synthesis inhibitor) were injected 
into the presumptive joint space of chick embryos at HH25 and joints analyzed at HH35/36.  
Versican has been shown in several studies to play a critical role in joint development. 
When versican levels were knocked down within the developing chick synovial joint, a 
decreased interzone area was noticed along with decreased hyaluronan expression in adeno-
infected locations (Nagchowdhuri et al., 2012).  Conditional versican knockout within a mouse 
model resulted in formation of limbs shortened in length and joints described as tilted 
(Choocheep et al., 2010).  When we overexpressed the G1 domain of versican in developing 
synovial joints we were able to distinguish a phenotype in whole mount samples consisting of a 
significantly enlarged interzone area in comparison to controls (Figure 3, Table 1). When 
hyaluronan expression was observed in sagittal sections of adeno-G1 infected chick limbs it was 
found that in areas with hemaglutinin-tagged recombinant G1, there was also more intense 
pericellular hyaluronan staining (Figure 1). This co-localization of adeno-G1 along with intense 
bHABP staining was also seen in a study that overexpressed the G1 domain within humeral 
primordia (Hudson et al., 2010). Since hyaluronan has been shown to help establish and maintain 
spaces (Pratt et al., 1975; Pitsillides et al., 1995), this increased hyaluronan accumulation in the 
presence of adeno-G1 provides an explanation for the increased interzone area seen within whole 
mount adenoviral treated limbs suggesting that endogenous versican proteolytic fragments 
containing the G1 domain (Capehart 2010) may interact with hyaluronan to increase cell spacing 
during joint formation. Previous work in the lab has demonstrated that overexpression of G1 
versican causes significant upregulation of hyaluronan pathway genes, including Hyal-2. 
Microarray data revealed an average 2.5 fold increase in Hyal-2 expression in the G1 treated 
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joint in comparison to controls and real-time PCR data revealed an approximate 2 fold 
upregulation of Hyal-2 in samples which overexpressed G1 versican (Vick 2012). Real-time 
PCR was performed on samples in the present study and although results were deemed 
insignificant, possibly due to small sample size or masking due to inclusion of RNA from 
surrounding tissues, a trend of increased Hyal-2 expression was seen in G1-treated joints in 
comparison to controls.  
Another necessity for synovial joint development is hyaluronan; knockout of HAS2, a 
hyaluronan synthase, in a mouse model resulted in extremely deformed limbs and absence or 
malformation of joints (Matsumoto et al., 2009). To assess hyaluronan’s possible role in G1-
mediated upregulation of Hyal-2, 4-methylumbelliferone was co-injected with the adeno-G1. 
Other studies have also utilized 4-methylumbelliferone to inhibit hyaluronan synthesis; a recent 
study using 4-methylumbelliferone in porcine trabecular meshwork cells recorded decreased 
hyaluronan synthesis and hyaluronan accumulation as seen in both ELISA and HABP staining 
(Keller et al., 2012). When 4-methylumbelliferone was co-injected with adeno-G1, chick limb 
sections and hyaluronan ELISA both revealed a decrease in overall hyaluronan accumulation in 
treated limbs in comparison to un-injected contralateral controls which is consistent with studies 
mentioned above. In areas where the adeno-G1 hemaglutinin tag was present, however, more 
intense hyaluronan staining was also seen as with adeno-G1 treatment alone, suggesting that the 
G1 versican is still capable of binding and retaining hyaluronan to a visible degree following 
treatment with 4-methylumbelliferone. Interestingly, whole mount data showed an increase in 
joint interzone spacing of limbs treated with 4-methylumbelliferone in conjunction with adeno-
G1 although there also appeared to be thinning of cartilage structures in the injected limbs, 
particularly in proximity to the targeted joint areas. Hyaluronan plays a major role in the 
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structural unit of cartilage (Sherman et al., 1994) and this decrease in overall hyaluronan 
accumulation and increased interzone area suggests that there could be disrupted cartilage 
formation causing diminished epiphyseal ends of the humerus, radius, and ulna which could 
account for increased spacing within the interzone. Real-time PCR results indicated a decrease in 
Hyal-2 expression in samples treated with 4-methylumbelliferone in conjunction with adeno-G1. 
This decrease in Hyal-2 expression alongside decreased hyaluronan accumulation seen in both 
the ELISA and bHABP staining results suggests that hyaluronan is necessary for G1-mediated 
upregulation of Hyal-2. Since results above indicate that G1-mediated signaling may be 
dependent on hyaluronan, it was important to also determine if CD44, a hyaluronan receptor, 
was playing a role in Hyal-2 upregulation. 
CD44 has been shown to bind, mediate internalization, and regulate degradation of 
hyaluronan (Knudson et al., 1993). In samples treated with DN-CD44 adenovirus alone, which 
likely blocks wild-type CD44-hyaluronan interactions, an increase in interzone area was also 
seen which suggests that levels of hyaluronan were increased within the interzone due to 
inability to be internalized by wild-type CD44 (Jiang et al., 2002). A similar result was seen in a 
study involving transgenic mice lacking detectable CD44 within skin keratinocytes and corneal 
epithelium; in response to the decrease in CD44 there was a large increase in hyaluronan 
accumulation since it was not able to be bound and internalized (Kaya et al., 1997). 
Unfortunately, due to low viability of treated embryos, histochemical analysis of hyaluronan 
changes as a result of DN-CD44 or adeno-DN-CD44 and G1 co-injection expression was not 
able to be accomplished in the present study and should be examined further in the future.  
Real time PCR revealed little change in Hyal-2 expression in response to adeno-DN-
CD44 in conjunction with adeno-G1 suggesting that CD44 does not have a role in G1-mediated 
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upregulation of Hyal-2. Whole mount samples that were treated with both adeno-G1 versican 
and DN-CD44 had a slight but insignificant increase in overall interzone area. Although 
insignificant, hyaluronan ELISA of adeno-G1 in conjunction with adeno-DN-CD44 revealed a 
trend of increased hyaluronan accumulation in joint tissue lysates which may provide an 
explanation for the increased interzone area seen in whole mounts. The hyaluronan ELISA trend 
suggests that G1-hyaluronan binding in addition to the inability of hyaluronan to be internalized 
by endogenous wild-type CD44 in the presence of DN-CD44 (Jiang et al., 2002) could cause 
more hyaluronan retention within the pericellular matrix. Moreover, there could be binding of 
hyaluronan to lower affinity receptors (such as the tailless CD44) present in the joint interzone 
when hyaluronan is bound to G1-versican. In a study of hyaluronan and cell surface CD44 in the 
presence of another hyaluronan binding protein, TSG-6 (tumor necrosis factor stimulated gene-6 
protein) it was found that if hyaluronan bound TSG-6 it was then capable of binding lower 
affinity receptors including a tailless form of CD44 (Lesley et al., 2004) very similar to the DN-
CD44 used in our study. Lesley’s results are consistent with results from the present study 
suggesting that hyaluronan may bind DN-CD44 (tailless form) whenever G1 is bound to 
hyaluronan which would cause increased hyaluronan accumulation in the developing joint. 
Alternatively, recent in situ hybridization analysis in our lab has identified another putative 
CD44 receptor within the interzone area, Sushi domain containing 5 (Susd5) located in carpal 
and elbow joints of the developing chick limb (Robins 2013).  Although function of Susd5 is 
unknown, it has a link domain similar to versican and CD44 capable of binding hyaluronan 
(Brissett et al., 1996; Vicent et al., 2008) and may represent a lower affinity receptor capable of 
binding hyaluronan-G1 versican potentially leading to a signaling cascade resulting in Hyal-2 
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upregulation. This possibility needs to be investigated in future studies in order to make 
definitive conclusions. 
In conclusion, during joint development the G1 domain of versican can be freed from the 
intact proteoglycan and may have a role in furthering joint development (Hudson et al., 2010; 
Capehart 2010). This G1 domain can bind and interact with hyaluronan and is capable of 
upregulating hyaluronan pathway genes when overexpressed within the developing chick joint. 
The decreased Hyal-2 expression in the presence of adeno-G1 in conjunction with 4-
methylumbelliferone suggests that G1-mediated signaling to upregulate Hyal-2 is dependent on 
the presence of hyaluronan. Based on preliminary results from this study, CD44 does not appear 
necessary for G1-mediated upregulation of Hyal-2. Further research needs to follow with CD44 
knockdown in combination with G1 overexpression in order to arrive at a definitive conclusion 
regarding its necessity for Hyal-2 upregulation and its effects on hyaluronan expression. 
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Appendix B: Representative Secondary Controls 
 
Sections stained with HA-7 primary antibody along with bHABP showed hemaglutinin-tagged 
adeno-G1 (A) and pericellular hyaluronan staining (C). Sections that were stained without a 
primary antibody showed minimal fluorescence when stained with goat, anti-mouse IgG FITC-
conjugated antibody (B) or TexasRed Streptavidin (D). 
